Vol 6-1 Commentary

Commentary: Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both IPF and non-IPF

James Patrick Finnerty

Department of Respiratory Medicine, Countess of Chester Hospital NHS Trust, Liverpool Road, Chester, UK

DOI: 10.29245/2689-999X/2022/1.1180 View / Download Pdf
Vol 6-1 Mini Review

Review: Technology and Techniques for Robotic-assisted Bronchoscopy

Jennifer D. Duke¹, Janani Reisenauer1,2*

1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA

2Division of Thoracic Surgery, Mayo Clinic, Rochester, MN, USA

With recent advancements in robotic bronchoscopy for peripheral pulmonary nodule biopsy, there has been notable improvements in reach, stability, and precision. Since 2017, the United States Food and Drug Administration (FDA) has approved two robotic devices, the Ion™ Endoluminal System (“Ion”) (Intuitive Surgical©, Sunnyvale, CA, USA) and the Monarch robotic system (Auris Health Inc, Redwood City, CA), for peripheral navigation and biopsy of lung lesions. We review these two robotic bronchoscopy systems and the literature that supports their use.

DOI: 10.29245/2689-999X/2022/1.1179 View / Download Pdf
Vol 5-2 Commentary

Commentary: Covid-19 Pneumonitis and Cystic Lung Disease, Pneumothorax and Pneumomediastinum

Serenydd Everden, Jack West

Department of Emergency Medicine, Coffs Harbour Base Hospital, Coffs Harbour, NSW, Australia

DOI: 10.29245/2689-999X/2021/2.1178 View / Download Pdf